BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Envision Healthcare Corporation (“Envision” or the “Company”) (NYSE: EVHC) securities between March 2, 2015 and July 21, 2017, inclusive (the “Class Period”). Envision investors have until October 3, 2017 to file a lead plaintiff motion.
Investors suffering losses on their Envision investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to firstname.lastname@example.org.
The complaint filed in this class action alleges that throughout the Class Period, Envision made materially false and/or misleading statements, and/or failed to disclose material information, about its business, operations and compliance policies. Furthermore, the complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period.
On July 24, 2017, The New York Times reported that physicians associated with Envision’s subsidiary EmCare Holdings Inc. were disproportionately likely to engage in practices referred to as “surprise billing” in which patients who go to in-network hospitals are treated by out-of-network doctors and subsequently billed at higher rates.
On this news, shares of Envision fell in value considerably, thereby damaging investors.
If you purchased shares of Envision during the Class Period you may move the Court no later than October 3, 2017 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.